Works by Nasroulah, Federico

Results: 4

Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: a subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trial.
Published in:
Japanese Journal of Clinical Oncology, 2023, v. 53, n. 1, p. 16, doi. 10.1093/jjco/hyac155
By:
- Tomita, Yoshihiko;
- Kobayashi, Ko;
- Kimura, Go;
- Oya, Mototsugu;
- Uemura, Hirotsugu;
- Nishiyama, Hiroyuki;
- Galsky, Matthew D;
- Nasroulah, Federico;
- Collette, Sandra;
- Broughton, Edward;
- Ünsal-Kaçmaz, Keziban;
- Kamisuki, Yukinori;
- Bajorin, Dean F
Publication type:
Article
Exposure-response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial.
Published in:
2017
By:
- Cohn, Allen;
- Yoshino, Takayuki;
- Heinemann, Volker;
- Obermannova, Radka;
- Bodoky, György;
- Prausová, Jana;
- Garcia-Carbonero, Rocio;
- Ciuleanu, Tudor;
- Garcia-Alfonso, Pilar;
- Portnoy, David;
- Van Cutsem, Eric;
- Yamazaki, Kentaro;
- Clingan, Philip;
- Polikoff, Jonathon;
- Lonardi, Sara;
- O'Brien, Lisa;
- Gao, Ling;
- Yang, Ling;
- Ferry, David;
- Nasroulah, Federico
Publication type:
journal article
Lack of pharmacokinetic drug-drug interaction between ramucirumab and irinotecan in patients with advanced solid tumors.
Published in:
2016
By:
- Wang, Ding;
- Braiteh, Fadi;
- Lee, James;
- Denlinger, Crystal;
- Shepard, Dale;
- Chaudhary, Archana;
- Lin, Yong;
- Gao, Ling;
- Asakiewicz, Christopher;
- Nasroulah, Federico;
- LoRusso, Patricia;
- Lee, James J;
- Denlinger, Crystal S;
- Shepard, Dale R
Publication type:
journal article
An Open-Label Phase II Study Evaluating the Safety and Efficacy of Ramucirumab Combined With mFOLFOX-6 as First-Line Therapy for Metastatic Colorectal Cancer.
Published in:
Oncologist, 2014, v. 19, n. 4, p. 350, doi. 10.1634/theoncologist.2014-0028
By:
- Garcia‐Carbonero, Rocio;
- Rivera, Fernando;
- Maurel, Joan;
- Ayoub, Jean‐Pierre M.;
- Moore, Malcolm J.;
- Cervantes, Andres;
- Asmis, Timothy R.;
- Schwartz, Jonathan D.;
- Nasroulah, Federico;
- Ballal, Shaila;
- Tabernero, Josep
Publication type:
Article

Works by Nasroulah, Federico

Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: a subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trial.

Exposure-response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial.

Lack of pharmacokinetic drug-drug interaction between ramucirumab and irinotecan in patients with advanced solid tumors.

An Open-Label Phase II Study Evaluating the Safety and Efficacy of Ramucirumab Combined With mFOLFOX-6 as First-Line Therapy for Metastatic Colorectal Cancer.